PortfoliosLab logoPortfoliosLab logo
WGS vs. OSCR
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

WGS vs. OSCR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in GeneDx Holdings Corp. (WGS) and Oscar Health, Inc. (OSCR). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, WGS achieves a -49.94% return, which is significantly lower than OSCR's 117.26% return.


WGS

1D
-5.58%
1M
-3.56%
6M
-32.36%
YTD
-49.94%
1Y
-35.92%
3Y*
104.44%
5Y*
-29.44%
10Y*
ALL TIME*
-24.38%

OSCR

1D
-0.03%
1M
-2.98%
6M
117.56%
YTD
117.26%
1Y
129.90%
3Y*
60.93%
5Y*
13.02%
10Y*
ALL TIME*
-2.60%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$128.55M$136.76M$181.50M
$43.35M$44.61M$68.76M

WGS vs. OSCR - Yearly Performance Comparison


2026 (YTD)20252024202320222021
WGS
GeneDx Holdings Corp.
-49.94%69.22%2,694.91%-68.41%-94.09%-77.42%
OSCR
Oscar Health, Inc.
117.26%6.92%46.89%271.95%-68.66%-78.19%

Correlation

The correlation between WGS and OSCR is 0.20, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.20

Correlation (3Y)
Balances recent behavior with more history.

0.15

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.25

Correlation (All Time)
Calculated using the full available price history since Mar 3, 2021

0.25

The correlation between WGS and OSCR shifts across timeframes, from 0.15 (3 years) to 0.25 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

WGS:

$1.93B

OSCR:

$8.09B

EPS

WGS:

-$2.75

OSCR:

-$0.14

PS Ratio

WGS:

4.17

OSCR:

0.68

PB Ratio

WGS:

7.52

OSCR:

6.19

Total Revenue (TTM)

WGS:

$442.68M

OSCR:

$13.30B

Gross Profit (TTM)

WGS:

$302.56M

OSCR:

$895.79M

EBITDA (TTM)

WGS:

-$51.08M

OSCR:

$19.23M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

WGS vs. OSCR — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

WGS
WGS Risk / Return Rank: 2929
Overall Rank
WGS Sharpe Ratio Rank: 2525
Sharpe Ratio Rank
WGS Sortino Ratio Rank: 3131
Sortino Ratio Rank
WGS Omega Ratio Rank: 3232
Omega Ratio Rank
WGS Calmar Ratio Rank: 2828
Calmar Ratio Rank
WGS Martin Ratio Rank: 2828
Martin Ratio Rank

OSCR
OSCR Risk / Return Rank: 8484
Overall Rank
OSCR Sharpe Ratio Rank: 8989
Sharpe Ratio Rank
OSCR Sortino Ratio Rank: 8787
Sortino Ratio Rank
OSCR Omega Ratio Rank: 8484
Omega Ratio Rank
OSCR Calmar Ratio Rank: 8282
Calmar Ratio Rank
OSCR Martin Ratio Rank: 7979
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

WGS vs. OSCR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for GeneDx Holdings Corp. (WGS) and Oscar Health, Inc. (OSCR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


WGSOSCRDifference
Sharpe ratioReturn per unit of total volatility

-2.17

Sortino ratioReturn per unit of downside risk

-2.57

Omega ratioGain probability vs. loss probability

0.99

1.30

-0.31

Calmar ratioReturn relative to maximum drawdown

-0.46

2.38

-2.83

Martin ratioReturn relative to average drawdown

-0.81

4.92

-5.73

WGS vs. OSCR - Sharpe Ratio Comparison

The current WGS Sharpe Ratio is -0.44, which is lower than the OSCR Sharpe Ratio of 1.73. The chart below compares the historical Sharpe Ratios of WGS and OSCR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

WGS vs. OSCR - Drawdown Comparison

The maximum WGS drawdown since its inception was -99.85%, which is greater than OSCR's maximum drawdown of -94.15%. Use the drawdown chart below to compare losses from any high point for WGS and OSCR.


Loading charts...

Drawdown Indicators


WGSOSCRDifference

Max Drawdown

Largest peak-to-trough decline

-99.85%

-94.15%

-5.70%

Max Drawdown (1Y)

Largest decline over 1 year

-79.40%

-51.71%

-27.69%

Max Drawdown (3Y)

Largest decline over 3 years

-82.63%

-53.39%

-29.24%

Max Drawdown (5Y)

Largest decline over 5 years

-99.69%

-88.23%

-11.46%

Current Drawdown

Current decline from peak

-92.36%

-15.09%

-77.27%

Average Drawdown

Average peak-to-trough decline

-83.56%

-63.84%

-19.72%

Ulcer Index

Depth and duration of drawdowns from previous peaks

44.51%

24.95%

+19.56%

Volatility

WGS vs. OSCR - Volatility Comparison

GeneDx Holdings Corp. (WGS) has a higher volatility of 20.98% compared to Oscar Health, Inc. (OSCR) at 15.53%. This indicates that WGS's price experiences larger fluctuations and is considered to be riskier than OSCR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


WGSOSCRDifference

Volatility (1M)

Calculated over the trailing 1-month period

20.98%

15.53%

+5.45%

Volatility (6M)

Calculated over the trailing 6-month period

86.94%

45.75%

+41.19%

Volatility (1Y)

Calculated over the trailing 1-year period

83.15%

70.91%

+12.24%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

110.05%

80.94%

+29.11%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

106.80%

79.51%

+27.29%

Dividends

WGS vs. OSCR - Dividend Comparison

Neither WGS nor OSCR has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

WGS vs. OSCR - Financials Comparison

This section allows you to compare key financial metrics between GeneDx Holdings Corp. and Oscar Health, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

WGS vs. OSCR - Profitability Comparison

The chart below illustrates the profitability comparison between GeneDx Holdings Corp. and Oscar Health, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

WGS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, GeneDx Holdings Corp. reported a gross profit of 68.21M and revenue of 102.25M. Therefore, the gross margin over that period was 66.7%.

OSCR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Oscar Health, Inc. reported a gross profit of 0.00 and revenue of 4.65B. Therefore, the gross margin over that period was 0.0%.

WGS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, GeneDx Holdings Corp. reported an operating income of -57.47M and revenue of 102.25M, resulting in an operating margin of -56.2%.

OSCR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Oscar Health, Inc. reported an operating income of 704.09M and revenue of 4.65B, resulting in an operating margin of 15.2%.

WGS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, GeneDx Holdings Corp. reported a net income of -63.32M and revenue of 102.25M, resulting in a net margin of -61.9%.

OSCR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Oscar Health, Inc. reported a net income of 679.00M and revenue of 4.65B, resulting in a net margin of 14.6%.


Frequently Asked Questions


WGS and OSCR have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

WGS has higher volatility (20.98%) compared to OSCR (15.53%). In terms of maximum drawdown, WGS dropped -99.85% vs OSCR's -94.15%.

OSCR currently has the higher Sharpe Ratio (1.73 vs -0.44), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for WGS and OSCR

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer